84 related articles for article (PubMed ID: 17577022)
21. High-resolution analysis of chromosome copy number alterations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified, with single nucleotide polymorphism-typing microarrays.
Fujiwara SI; Yamashita Y; Nakamura N; Choi YL; Ueno T; Watanabe H; Kurashina K; Soda M; Enomoto M; Hatanaka H; Takada S; Abe M; Ozawa K; Mano H
Leukemia; 2008 Oct; 22(10):1891-8. PubMed ID: 18633432
[TBL] [Abstract][Full Text] [Related]
22. Non-overlapping and non-cell-type-specific gene expression signatures predict lung cancer survival.
Sun Z; Wigle DA; Yang P
J Clin Oncol; 2008 Feb; 26(6):877-83. PubMed ID: 18281660
[TBL] [Abstract][Full Text] [Related]
23. Peripheral T-cell lymphoma gene expression profiles.
Martinez-Delgado B
Hematol Oncol; 2006 Sep; 24(3):113-9. PubMed ID: 16676369
[TBL] [Abstract][Full Text] [Related]
24. Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations.
Petit B; Leroy K; Kanavaros P; Boulland ML; Druet-Cabanac M; Haioun C; Bordessoule D; Gaulard P
Hum Pathol; 2001 Feb; 32(2):196-204. PubMed ID: 11230707
[TBL] [Abstract][Full Text] [Related]
25. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
[TBL] [Abstract][Full Text] [Related]
26. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
[TBL] [Abstract][Full Text] [Related]
27. Comparison of peripheral T-cell lymphomas and diffuse large B-cell lymphoma.
Tomita N; Motomura S; Hyo R; Takasaki H; Takemura S; Taguchi J; Fujisawa S; Ogawa K; Ishigatsubo Y; Takeuchi K
Cancer; 2007 Mar; 109(6):1146-51. PubMed ID: 17311304
[TBL] [Abstract][Full Text] [Related]
28. [Paraneoplastic lymphadenopathy].
Melikian AL; Nikitin EA; Kaplanskaia IB; Frank GA
Ter Arkh; 2007; 79(8):44-52. PubMed ID: 17926471
[TBL] [Abstract][Full Text] [Related]
29. Somatic hypermutation signature in B-cell low-grade lymphomas.
Tracey L; Aggarwal M; García-Cosio M; Villuendas R; Algara P; Sánchez-Beato M; Sánchez-Aguilera A; García JF; Rodríguez A; Camacho FI; Martínez N; Ruiz-Ballesteros E; Mollejo M; Piris MA
Haematologica; 2008 Aug; 93(8):1186-94. PubMed ID: 18556400
[TBL] [Abstract][Full Text] [Related]
30. Expression of three cell proliferation-associated antigens, DNA polymerase alpha, Ki-67 antigen and transferrin receptor in nodal and cutaneous T-cell lymphomas.
Mitani S; Tango T; Sonobe Y; Baba N; Nagatani T; Nomoto S; Mori S
Int J Hematol; 1991 Oct; 54(5):385-93. PubMed ID: 1756249
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic and prognostic significance of gene expression profiling in lymphomas.
Leich E; Hartmann EM; Burek C; Ott G; Rosenwald A
APMIS; 2007 Oct; 115(10):1135-46. PubMed ID: 18042147
[TBL] [Abstract][Full Text] [Related]
32. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
33. Distinct gene expression profiles: nodal versus extranodal diffuse large B-cell lymphoma.
Jehan Z; Siraj AK; Abubaker J; Ruiz C; Simon R; Sultana M; Uddin S; Bavi P; Hussain A; Razack S; Ezzat A; Al-Dayel F; Sauter G; Al-Kuraya KS
Oncology; 2008; 75(1-2):71-80. PubMed ID: 18784434
[TBL] [Abstract][Full Text] [Related]
34. Apoptotic rate in peripheral T-cell lymphomas. A study using a tissue microarray with validation on full tissue sections.
Rassidakis GZ; Jones D; Thomaides A; Sen F; Lai R; Cabanillas F; McDonnell TJ; Medeiros LJ
Am J Clin Pathol; 2002 Sep; 118(3):328-34. PubMed ID: 12219774
[TBL] [Abstract][Full Text] [Related]
35. Perforin and granzyme expression in cytotoxic T-cell lymphomas.
Yamashita Y; Yatabe Y; Tsuzuki T; Nakayama A; Hasegawa Y; Kojima H; Nagasawa T; Mori N
Mod Pathol; 1998 Apr; 11(4):313-23. PubMed ID: 9578080
[TBL] [Abstract][Full Text] [Related]
36. The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival.
Martínez N; Camacho FI; Algara P; Rodríguez A; Dopazo A; Ruíz-Ballesteros E; Martín P; Martínez-Climent JA; García-Conde J; Menárguez J; Solano F; Mollejo M; Piris MA
Cancer Res; 2003 Dec; 63(23):8226-32. PubMed ID: 14678979
[TBL] [Abstract][Full Text] [Related]
37. Primary cutaneous follicular helper T-cell lymphoma: a new subtype of cutaneous T-cell lymphoma reported in a series of 5 cases.
Battistella M; Beylot-Barry M; Bachelez H; Rivet J; Vergier B; Bagot M
Arch Dermatol; 2012 Jul; 148(7):832-9. PubMed ID: 22508770
[TBL] [Abstract][Full Text] [Related]
38. BCL10 down-regulation in peripheral T-cell lymphomas.
Rossi M; Agostinelli C; Righi S; Sabattini E; Bacci F; Gazzola A; Pileri SA; Piccaluga PP
Hum Pathol; 2012 Dec; 43(12):2266-73. PubMed ID: 22818167
[TBL] [Abstract][Full Text] [Related]
39. Peripheral T-cell lymphoma classification: the matter of cellular derivation.
Piccaluga PP; Agostinelli C; Tripodo C; Gazzola A; Bacci F; Sabattini E; Pileri SA;
Expert Rev Hematol; 2011 Aug; 4(4):415-25. PubMed ID: 21801133
[TBL] [Abstract][Full Text] [Related]
40. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.
Vose J; Armitage J; Weisenburger D;
J Clin Oncol; 2008 Sep; 26(25):4124-30. PubMed ID: 18626005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
